ショートペプチド経腸栄養剤の世界市場成長 2023-2029Global Short Peptide Enteral Nutrition Market Growth 2023-2029 弊社(LP Info Research)の最新調査によると、世界の短ペプチド経腸栄養剤市場規模は2022年に100万米ドルと評価されました。川下市場での需要の増加とCOVID-19やロシア・ウクライナ戦争の影響からの回復により、... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー弊社(LP Info Research)の最新調査によると、世界の短ペプチド経腸栄養剤市場規模は2022年に100万米ドルと評価されました。川下市場での需要の増加とCOVID-19やロシア・ウクライナ戦争の影響からの回復により、短ペプチド経腸栄養剤はレビュー期間中のCAGR%で2029年までに百万米ドルの再調整された規模になると予測されています。この調査レポートは、世界の短ペプチド経腸栄養剤市場の成長可能性を明らかにしています。COVID-19とロシア・ウクライナ戦争の影響からの回復に伴い、短ペプチド経腸栄養剤は今後の市場で安定した成長を示すと予想される。しかし、短ペプチド経腸栄養剤の普及には、製品の差別化、コストの削減、サプライチェーンの最適化が引き続き不可欠である。市場参加者は、ショートペプチド経腸栄養剤市場がもたらす莫大な機会を活用するために、研究開発に投資し、戦略的パートナーシップを構築し、進化する消費者の嗜好に合わせた製品を提供する必要がある。 ショートペプチド経腸栄養剤は、臨床経腸栄養サポートに使用される様々な製品の総称であり、その栄養組成には主に様々なタンパク質、アミノ酸、糖質、脂質、ビタミン、ミネラル、食物繊維などのバランスが含まれている。原料は主に陸上の動植物抽出物に由来する。 主な特徴 ショートペプチド経腸栄養市場は様々な側面を反映し、業界に対する貴重な洞察を提供します。 市場規模と成長:この調査レポートは、ショートペプチド経腸栄養剤市場の現在の規模と成長の概要を提供します。過去データ、タイプ別市場区分(粉末タイプ、懸濁タイプなど)、地域別内訳などが含まれる場合があります。 市場の促進要因と課題:レポートでは、政府規制、環境問題、技術の進歩、消費者の嗜好の変化など、短時間ペプチド経腸栄養剤市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制限、射程距離への不安、初期コストの高さなど、業界が直面する課題も浮き彫りにすることができる。 競合情勢:この調査レポートは、短期ペプチド経腸栄養市場内の競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれる。また、新興企業や市場に与える潜在的な影響にもスポットを当てています。 技術開発:調査レポートは、短鎖ペプチド経腸栄養剤業界における最新の技術開発を掘り下げることができます。これには、短ペプチド経腸栄養剤技術の進歩、短ペプチド経腸栄養剤の新規参入企業、短ペプチド経腸栄養剤の新規投資、短ペプチド経腸栄養剤の将来を形作るその他のイノベーションなどが含まれる。 川下の事業者の好み:このレポートは、短鎖ペプチド経腸栄養剤市場における顧客の購買行動と採用動向を明らかにすることができます。このレポートには、顧客の購買決定、短小ペプチド経腸栄養製品の嗜好に影響を与える要因が含まれています。 政府の政策とインセンティブ:調査レポートは、政府の政策とインセンティブが短ペプチド経腸栄養市場に与える影響を分析します。これには、規制枠組み、補助金、税制優遇措置、および短小ペプチド経腸栄養剤市場の促進を目的としたその他の措置の評価が含まれる。また、市場成長促進におけるこれらの政策の有効性も評価する。 環境への影響と持続可能性調査レポートは、短ペプチド経腸栄養剤市場の環境影響と持続可能性の側面を評価します。 市場予測と将来展望:調査レポートでは、実施した分析に基づいて、短小ペプチド経腸栄養剤産業の市場予測と展望を提供しています。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。 提言と機会:本レポートは、業界関係者、政策立案者、投資家への提言で締めくくられています。市場関係者が新たなトレンドを活用し、課題を克服し、短時間ペプチド経腸栄養市場の成長と発展に貢献するための潜在的な機会を強調しています。 市場の細分化 ショートペプチド経腸栄養剤市場は、タイプ別と用途別に分割される。2018年から2029年までの期間について、セグメント間の成長により、タイプ別、用途別の消費額の正確な計算と予測を数量と金額で提供します。 タイプ別セグメント 粉末タイプ 懸濁液タイプ エマルジョンタイプ その他 用途別セグメント 病原性疾患 栄養欠乏症 遺伝性疾患 精神疾患 その他 本レポートではまた、市場を地域別に分けています: 南北アメリカ アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、一次専門家から収集したインプットと、企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。 ホスピーラ フレゼニウス・カビ ダノン ノウメディカル ネスレ B.ブラウン・メルサンゲンAG アボット 大塚ファーマシューティカル・インディア ニュートリケム・ディエット+ファーマ社 デルタ・ドラッグ バクスター アラガン アクタビス グリフォルス ビフォーファーマ 本レポートで扱う主な質問 世界の短小ペプチド経腸栄養剤市場の10年展望は? 世界および地域別に、短ペプチド経腸栄養剤市場の成長を促進する要因は何か? 市場別、地域別で最も急成長する技術は何か? 短小ペプチド経腸栄養剤の市場機会は最終市場規模によってどのように異なるのか? 短小ペプチド経腸栄養剤のタイプ、用途別内訳は? COVID-19とロシア・ウクライナ戦争の影響は? 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Short Peptide Enteral Nutrition Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Short Peptide Enteral Nutrition by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Short Peptide Enteral Nutrition by Country/Region, 2018, 2022 & 2029 2.2 Short Peptide Enteral Nutrition Segment by Type 2.2.1 Powdered Type 2.2.2 Suspension Type 2.2.3 Emulsion Type 2.2.4 Others 2.3 Short Peptide Enteral Nutrition Sales by Type 2.3.1 Global Short Peptide Enteral Nutrition Sales Market Share by Type (2018-2023) 2.3.2 Global Short Peptide Enteral Nutrition Revenue and Market Share by Type (2018-2023) 2.3.3 Global Short Peptide Enteral Nutrition Sale Price by Type (2018-2023) 2.4 Short Peptide Enteral Nutrition Segment by Application 2.4.1 Pathogenic Diseases 2.4.2 Nutritional Deficiency Diseases 2.4.3 Genetic Diseases 2.4.4 Psychological Diseases 2.4.5 Other 2.5 Short Peptide Enteral Nutrition Sales by Application 2.5.1 Global Short Peptide Enteral Nutrition Sale Market Share by Application (2018-2023) 2.5.2 Global Short Peptide Enteral Nutrition Revenue and Market Share by Application (2018-2023) 2.5.3 Global Short Peptide Enteral Nutrition Sale Price by Application (2018-2023) 3 Global Short Peptide Enteral Nutrition by Company 3.1 Global Short Peptide Enteral Nutrition Breakdown Data by Company 3.1.1 Global Short Peptide Enteral Nutrition Annual Sales by Company (2018-2023) 3.1.2 Global Short Peptide Enteral Nutrition Sales Market Share by Company (2018-2023) 3.2 Global Short Peptide Enteral Nutrition Annual Revenue by Company (2018-2023) 3.2.1 Global Short Peptide Enteral Nutrition Revenue by Company (2018-2023) 3.2.2 Global Short Peptide Enteral Nutrition Revenue Market Share by Company (2018-2023) 3.3 Global Short Peptide Enteral Nutrition Sale Price by Company 3.4 Key Manufacturers Short Peptide Enteral Nutrition Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Short Peptide Enteral Nutrition Product Location Distribution 3.4.2 Players Short Peptide Enteral Nutrition Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Short Peptide Enteral Nutrition by Geographic Region 4.1 World Historic Short Peptide Enteral Nutrition Market Size by Geographic Region (2018-2023) 4.1.1 Global Short Peptide Enteral Nutrition Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Short Peptide Enteral Nutrition Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Short Peptide Enteral Nutrition Market Size by Country/Region (2018-2023) 4.2.1 Global Short Peptide Enteral Nutrition Annual Sales by Country/Region (2018-2023) 4.2.2 Global Short Peptide Enteral Nutrition Annual Revenue by Country/Region (2018-2023) 4.3 Americas Short Peptide Enteral Nutrition Sales Growth 4.4 APAC Short Peptide Enteral Nutrition Sales Growth 4.5 Europe Short Peptide Enteral Nutrition Sales Growth 4.6 Middle East & Africa Short Peptide Enteral Nutrition Sales Growth 5 Americas 5.1 Americas Short Peptide Enteral Nutrition Sales by Country 5.1.1 Americas Short Peptide Enteral Nutrition Sales by Country (2018-2023) 5.1.2 Americas Short Peptide Enteral Nutrition Revenue by Country (2018-2023) 5.2 Americas Short Peptide Enteral Nutrition Sales by Type 5.3 Americas Short Peptide Enteral Nutrition Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Short Peptide Enteral Nutrition Sales by Region 6.1.1 APAC Short Peptide Enteral Nutrition Sales by Region (2018-2023) 6.1.2 APAC Short Peptide Enteral Nutrition Revenue by Region (2018-2023) 6.2 APAC Short Peptide Enteral Nutrition Sales by Type 6.3 APAC Short Peptide Enteral Nutrition Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Short Peptide Enteral Nutrition by Country 7.1.1 Europe Short Peptide Enteral Nutrition Sales by Country (2018-2023) 7.1.2 Europe Short Peptide Enteral Nutrition Revenue by Country (2018-2023) 7.2 Europe Short Peptide Enteral Nutrition Sales by Type 7.3 Europe Short Peptide Enteral Nutrition Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Short Peptide Enteral Nutrition by Country 8.1.1 Middle East & Africa Short Peptide Enteral Nutrition Sales by Country (2018-2023) 8.1.2 Middle East & Africa Short Peptide Enteral Nutrition Revenue by Country (2018-2023) 8.2 Middle East & Africa Short Peptide Enteral Nutrition Sales by Type 8.3 Middle East & Africa Short Peptide Enteral Nutrition Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Short Peptide Enteral Nutrition 10.3 Manufacturing Process Analysis of Short Peptide Enteral Nutrition 10.4 Industry Chain Structure of Short Peptide Enteral Nutrition 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Short Peptide Enteral Nutrition Distributors 11.3 Short Peptide Enteral Nutrition Customer 12 World Forecast Review for Short Peptide Enteral Nutrition by Geographic Region 12.1 Global Short Peptide Enteral Nutrition Market Size Forecast by Region 12.1.1 Global Short Peptide Enteral Nutrition Forecast by Region (2024-2029) 12.1.2 Global Short Peptide Enteral Nutrition Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Short Peptide Enteral Nutrition Forecast by Type 12.7 Global Short Peptide Enteral Nutrition Forecast by Application 13 Key Players Analysis 13.1 Hospira Inc 13.1.1 Hospira Inc Company Information 13.1.2 Hospira Inc Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.1.3 Hospira Inc Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Hospira Inc Main Business Overview 13.1.5 Hospira Inc Latest Developments 13.2 Fresenius Kabi 13.2.1 Fresenius Kabi Company Information 13.2.2 Fresenius Kabi Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.2.3 Fresenius Kabi Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Fresenius Kabi Main Business Overview 13.2.5 Fresenius Kabi Latest Developments 13.3 Danone 13.3.1 Danone Company Information 13.3.2 Danone Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.3.3 Danone Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Danone Main Business Overview 13.3.5 Danone Latest Developments 13.4 Knowmedical 13.4.1 Knowmedical Company Information 13.4.2 Knowmedical Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.4.3 Knowmedical Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Knowmedical Main Business Overview 13.4.5 Knowmedical Latest Developments 13.5 Nestlé 13.5.1 Nestlé Company Information 13.5.2 Nestlé Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.5.3 Nestlé Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Nestlé Main Business Overview 13.5.5 Nestlé Latest Developments 13.6 B. Braun Melsungen AG 13.6.1 B. Braun Melsungen AG Company Information 13.6.2 B. Braun Melsungen AG Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.6.3 B. Braun Melsungen AG Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 B. Braun Melsungen AG Main Business Overview 13.6.5 B. Braun Melsungen AG Latest Developments 13.7 Abbott 13.7.1 Abbott Company Information 13.7.2 Abbott Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.7.3 Abbott Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Abbott Main Business Overview 13.7.5 Abbott Latest Developments 13.8 Otsuka Pharmaceutical India Private Limited 13.8.1 Otsuka Pharmaceutical India Private Limited Company Information 13.8.2 Otsuka Pharmaceutical India Private Limited Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.8.3 Otsuka Pharmaceutical India Private Limited Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Otsuka Pharmaceutical India Private Limited Main Business Overview 13.8.5 Otsuka Pharmaceutical India Private Limited Latest Developments 13.9 NUTRICHEM DIÄT + PHARMA GMBH 13.9.1 NUTRICHEM DIÄT + PHARMA GMBH Company Information 13.9.2 NUTRICHEM DIÄT + PHARMA GMBH Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.9.3 NUTRICHEM DIÄT + PHARMA GMBH Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 NUTRICHEM DIÄT + PHARMA GMBH Main Business Overview 13.9.5 NUTRICHEM DIÄT + PHARMA GMBH Latest Developments 13.10 Delta Drugs 13.10.1 Delta Drugs Company Information 13.10.2 Delta Drugs Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.10.3 Delta Drugs Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 Delta Drugs Main Business Overview 13.10.5 Delta Drugs Latest Developments 13.11 Baxter 13.11.1 Baxter Company Information 13.11.2 Baxter Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.11.3 Baxter Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 Baxter Main Business Overview 13.11.5 Baxter Latest Developments 13.12 Allergan 13.12.1 Allergan Company Information 13.12.2 Allergan Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.12.3 Allergan Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 Allergan Main Business Overview 13.12.5 Allergan Latest Developments 13.13 Actavis Inc. 13.13.1 Actavis Inc. Company Information 13.13.2 Actavis Inc. Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.13.3 Actavis Inc. Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.13.4 Actavis Inc. Main Business Overview 13.13.5 Actavis Inc. Latest Developments 13.14 Grifols, S.A. 13.14.1 Grifols, S.A. Company Information 13.14.2 Grifols, S.A. Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.14.3 Grifols, S.A. Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.14.4 Grifols, S.A. Main Business Overview 13.14.5 Grifols, S.A. Latest Developments 13.15 Vifor Pharma 13.15.1 Vifor Pharma Company Information 13.15.2 Vifor Pharma Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.15.3 Vifor Pharma Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.15.4 Vifor Pharma Main Business Overview 13.15.5 Vifor Pharma Latest Developments 14 Research Findings and Conclusion
SummaryAccording to our (LP Info Research) latest study, the global Short Peptide Enteral Nutrition market size was valued at US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Short Peptide Enteral Nutrition is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Short Peptide Enteral Nutrition Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Short Peptide Enteral Nutrition by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Short Peptide Enteral Nutrition by Country/Region, 2018, 2022 & 2029 2.2 Short Peptide Enteral Nutrition Segment by Type 2.2.1 Powdered Type 2.2.2 Suspension Type 2.2.3 Emulsion Type 2.2.4 Others 2.3 Short Peptide Enteral Nutrition Sales by Type 2.3.1 Global Short Peptide Enteral Nutrition Sales Market Share by Type (2018-2023) 2.3.2 Global Short Peptide Enteral Nutrition Revenue and Market Share by Type (2018-2023) 2.3.3 Global Short Peptide Enteral Nutrition Sale Price by Type (2018-2023) 2.4 Short Peptide Enteral Nutrition Segment by Application 2.4.1 Pathogenic Diseases 2.4.2 Nutritional Deficiency Diseases 2.4.3 Genetic Diseases 2.4.4 Psychological Diseases 2.4.5 Other 2.5 Short Peptide Enteral Nutrition Sales by Application 2.5.1 Global Short Peptide Enteral Nutrition Sale Market Share by Application (2018-2023) 2.5.2 Global Short Peptide Enteral Nutrition Revenue and Market Share by Application (2018-2023) 2.5.3 Global Short Peptide Enteral Nutrition Sale Price by Application (2018-2023) 3 Global Short Peptide Enteral Nutrition by Company 3.1 Global Short Peptide Enteral Nutrition Breakdown Data by Company 3.1.1 Global Short Peptide Enteral Nutrition Annual Sales by Company (2018-2023) 3.1.2 Global Short Peptide Enteral Nutrition Sales Market Share by Company (2018-2023) 3.2 Global Short Peptide Enteral Nutrition Annual Revenue by Company (2018-2023) 3.2.1 Global Short Peptide Enteral Nutrition Revenue by Company (2018-2023) 3.2.2 Global Short Peptide Enteral Nutrition Revenue Market Share by Company (2018-2023) 3.3 Global Short Peptide Enteral Nutrition Sale Price by Company 3.4 Key Manufacturers Short Peptide Enteral Nutrition Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Short Peptide Enteral Nutrition Product Location Distribution 3.4.2 Players Short Peptide Enteral Nutrition Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Short Peptide Enteral Nutrition by Geographic Region 4.1 World Historic Short Peptide Enteral Nutrition Market Size by Geographic Region (2018-2023) 4.1.1 Global Short Peptide Enteral Nutrition Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Short Peptide Enteral Nutrition Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Short Peptide Enteral Nutrition Market Size by Country/Region (2018-2023) 4.2.1 Global Short Peptide Enteral Nutrition Annual Sales by Country/Region (2018-2023) 4.2.2 Global Short Peptide Enteral Nutrition Annual Revenue by Country/Region (2018-2023) 4.3 Americas Short Peptide Enteral Nutrition Sales Growth 4.4 APAC Short Peptide Enteral Nutrition Sales Growth 4.5 Europe Short Peptide Enteral Nutrition Sales Growth 4.6 Middle East & Africa Short Peptide Enteral Nutrition Sales Growth 5 Americas 5.1 Americas Short Peptide Enteral Nutrition Sales by Country 5.1.1 Americas Short Peptide Enteral Nutrition Sales by Country (2018-2023) 5.1.2 Americas Short Peptide Enteral Nutrition Revenue by Country (2018-2023) 5.2 Americas Short Peptide Enteral Nutrition Sales by Type 5.3 Americas Short Peptide Enteral Nutrition Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Short Peptide Enteral Nutrition Sales by Region 6.1.1 APAC Short Peptide Enteral Nutrition Sales by Region (2018-2023) 6.1.2 APAC Short Peptide Enteral Nutrition Revenue by Region (2018-2023) 6.2 APAC Short Peptide Enteral Nutrition Sales by Type 6.3 APAC Short Peptide Enteral Nutrition Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Short Peptide Enteral Nutrition by Country 7.1.1 Europe Short Peptide Enteral Nutrition Sales by Country (2018-2023) 7.1.2 Europe Short Peptide Enteral Nutrition Revenue by Country (2018-2023) 7.2 Europe Short Peptide Enteral Nutrition Sales by Type 7.3 Europe Short Peptide Enteral Nutrition Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Short Peptide Enteral Nutrition by Country 8.1.1 Middle East & Africa Short Peptide Enteral Nutrition Sales by Country (2018-2023) 8.1.2 Middle East & Africa Short Peptide Enteral Nutrition Revenue by Country (2018-2023) 8.2 Middle East & Africa Short Peptide Enteral Nutrition Sales by Type 8.3 Middle East & Africa Short Peptide Enteral Nutrition Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Short Peptide Enteral Nutrition 10.3 Manufacturing Process Analysis of Short Peptide Enteral Nutrition 10.4 Industry Chain Structure of Short Peptide Enteral Nutrition 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Short Peptide Enteral Nutrition Distributors 11.3 Short Peptide Enteral Nutrition Customer 12 World Forecast Review for Short Peptide Enteral Nutrition by Geographic Region 12.1 Global Short Peptide Enteral Nutrition Market Size Forecast by Region 12.1.1 Global Short Peptide Enteral Nutrition Forecast by Region (2024-2029) 12.1.2 Global Short Peptide Enteral Nutrition Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Short Peptide Enteral Nutrition Forecast by Type 12.7 Global Short Peptide Enteral Nutrition Forecast by Application 13 Key Players Analysis 13.1 Hospira Inc 13.1.1 Hospira Inc Company Information 13.1.2 Hospira Inc Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.1.3 Hospira Inc Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Hospira Inc Main Business Overview 13.1.5 Hospira Inc Latest Developments 13.2 Fresenius Kabi 13.2.1 Fresenius Kabi Company Information 13.2.2 Fresenius Kabi Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.2.3 Fresenius Kabi Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Fresenius Kabi Main Business Overview 13.2.5 Fresenius Kabi Latest Developments 13.3 Danone 13.3.1 Danone Company Information 13.3.2 Danone Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.3.3 Danone Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Danone Main Business Overview 13.3.5 Danone Latest Developments 13.4 Knowmedical 13.4.1 Knowmedical Company Information 13.4.2 Knowmedical Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.4.3 Knowmedical Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Knowmedical Main Business Overview 13.4.5 Knowmedical Latest Developments 13.5 Nestlé 13.5.1 Nestlé Company Information 13.5.2 Nestlé Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.5.3 Nestlé Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Nestlé Main Business Overview 13.5.5 Nestlé Latest Developments 13.6 B. Braun Melsungen AG 13.6.1 B. Braun Melsungen AG Company Information 13.6.2 B. Braun Melsungen AG Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.6.3 B. Braun Melsungen AG Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 B. Braun Melsungen AG Main Business Overview 13.6.5 B. Braun Melsungen AG Latest Developments 13.7 Abbott 13.7.1 Abbott Company Information 13.7.2 Abbott Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.7.3 Abbott Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Abbott Main Business Overview 13.7.5 Abbott Latest Developments 13.8 Otsuka Pharmaceutical India Private Limited 13.8.1 Otsuka Pharmaceutical India Private Limited Company Information 13.8.2 Otsuka Pharmaceutical India Private Limited Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.8.3 Otsuka Pharmaceutical India Private Limited Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Otsuka Pharmaceutical India Private Limited Main Business Overview 13.8.5 Otsuka Pharmaceutical India Private Limited Latest Developments 13.9 NUTRICHEM DIÄT + PHARMA GMBH 13.9.1 NUTRICHEM DIÄT + PHARMA GMBH Company Information 13.9.2 NUTRICHEM DIÄT + PHARMA GMBH Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.9.3 NUTRICHEM DIÄT + PHARMA GMBH Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 NUTRICHEM DIÄT + PHARMA GMBH Main Business Overview 13.9.5 NUTRICHEM DIÄT + PHARMA GMBH Latest Developments 13.10 Delta Drugs 13.10.1 Delta Drugs Company Information 13.10.2 Delta Drugs Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.10.3 Delta Drugs Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 Delta Drugs Main Business Overview 13.10.5 Delta Drugs Latest Developments 13.11 Baxter 13.11.1 Baxter Company Information 13.11.2 Baxter Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.11.3 Baxter Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 Baxter Main Business Overview 13.11.5 Baxter Latest Developments 13.12 Allergan 13.12.1 Allergan Company Information 13.12.2 Allergan Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.12.3 Allergan Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 Allergan Main Business Overview 13.12.5 Allergan Latest Developments 13.13 Actavis Inc. 13.13.1 Actavis Inc. Company Information 13.13.2 Actavis Inc. Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.13.3 Actavis Inc. Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.13.4 Actavis Inc. Main Business Overview 13.13.5 Actavis Inc. Latest Developments 13.14 Grifols, S.A. 13.14.1 Grifols, S.A. Company Information 13.14.2 Grifols, S.A. Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.14.3 Grifols, S.A. Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.14.4 Grifols, S.A. Main Business Overview 13.14.5 Grifols, S.A. Latest Developments 13.15 Vifor Pharma 13.15.1 Vifor Pharma Company Information 13.15.2 Vifor Pharma Short Peptide Enteral Nutrition Product Portfolios and Specifications 13.15.3 Vifor Pharma Short Peptide Enteral Nutrition Sales, Revenue, Price and Gross Margin (2018-2023) 13.15.4 Vifor Pharma Main Business Overview 13.15.5 Vifor Pharma Latest Developments 14 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポート
LP Information社の医薬品・ヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD(peptide)の最新刊レポートよくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/12/23 10:26 157.72 円 164.94 円 201.11 円 |